Fluorescent dye guides Stomach-Sparing surgery for early cancer

NCT ID NCT07708012

ENROLLING_BY_INVITATION Disease control Sponsor: wangdongsheng Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests a surgical technique for early stomach cancer that combines a camera in the abdomen (laparoscopy) with a flexible tube down the throat (endoscopy). Doctors inject a fluorescent dye near the tumor to highlight the first lymph nodes that might contain cancer. If those nodes are cancer-free, they remove only the tumor and a small part of the stomach, preserving more normal function. The goal is to see if this approach is safe and effective while reducing side effects compared to standard surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combined laparoscopic and endoscopic surgical procedure using fluorescent dye (indocyanine green) to identify and remove sentinel lymph nodes and the primary tumor
What this could lead to
If successful, this approach could offer a less invasive, stomach-preserving surgical option for early stomach cancer patients, reducing long-term side effects.
What could go wrong
This is a small, single-center study with only 30 participants, so results may not apply broadly. The procedure's safety and effectiveness need confirmation in larger trials.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Qingdao University Affiliated Hospital West Coast Campus

    Qingdao, Shandong, 266000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.